181 related articles for article (PubMed ID: 22629598)
1. [The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo].
Ramenskaia GV; Shokhin IE; Savchenko AIu; Volkova EA
Biomed Khim; 2011; 57(5):482-9. PubMed ID: 22629598
[TBL] [Abstract][Full Text] [Related]
2. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
Do TT; Van Speybroeck M; Mols R; Annaert P; Martens J; Van Humbeeck J; Vermant J; Augustijns P; Van den Mooter G
Int J Pharm; 2011 Jul; 414(1-2):118-24. PubMed ID: 21596119
[TBL] [Abstract][Full Text] [Related]
3. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
Wei H; Löbenberg R
Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
[TBL] [Abstract][Full Text] [Related]
4. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
5. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
6. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
7. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
8. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
9. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
[TBL] [Abstract][Full Text] [Related]
10. Dissolution behavior of various drugs in different FaSSIF versions.
Klumpp L; Leigh M; Dressman J
Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
[TBL] [Abstract][Full Text] [Related]
11. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
12. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
13.
Silva TMD; Honorio TDS; Chaves MHDC; Duque MD; Cabral LM; Patricio BFC; Rocha HVA
Drug Dev Ind Pharm; 2021 Aug; 47(8):1342-1352. PubMed ID: 34622730
[TBL] [Abstract][Full Text] [Related]
14. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
15. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
[TBL] [Abstract][Full Text] [Related]
16. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
[TBL] [Abstract][Full Text] [Related]
17. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
Ottaviani G; Wendelspiess S; Alvarez-Sánchez R
Mol Pharm; 2015 Apr; 12(4):1171-9. PubMed ID: 25665011
[TBL] [Abstract][Full Text] [Related]
18. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
19. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
Kleberg K; Jacobsen J; Müllertz A
J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
[TBL] [Abstract][Full Text] [Related]
20. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
